Bioenvision, Inc. (BIVN)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Bioenvision, Inc. (BIVN)
13 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on BIVN
Most popular authors
(tracked in watchlists)
- Alan Brochstein(222)
- Thomas Tan(124)
- Lon Juricic(15)
- Thomas Englebert(14)
- Centient Biotech Investor(3)
Most commented on authors
- Alan Brochstein(16)
- Thomas Tan(2)
- H.S. Ayoub(1)
- Lon Juricic(0)
- Centient Biotech Investor(0)
- Cancer Stocks: Lagging Again
- Cancer Stocks: The Bleeding Slows
- Cancer Stocks Hammered Once Again
- SCO Capital's Objection to Bioenvision/Genzyme Merger Continues
- Cancer Stocks Slide Again
- Cancer Stocks Plunge Following ASCO Meeting
- Eye on Bioenvision
- Cancer Stocks Soar With Annual ASCO Meeting
- Cancer Stocks on the Go: Winners and Losers
- Bioenvision: Smallcap Biotech Worth Watching
- Biotech Stocks Day-in-Review: IPOs Heat Up
- Hematology Meeting to Boost Amgen, Biogen Idec and Other Biotechs
-
Earnings Schedule & Estimates for Monday, September 11, 2006
on Sep 11, 2006
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »